Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Progesterone, and what generic alternatives are available?

Progesterone is a drug marketed by Amneal Pharms Ny, Bionpharma Inc, Dr Reddys Labs Inc, Sandoz Inc, Sofgen Pharms, Teva Pharms, Actavis Labs Ut Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Lilly, and Luitpold. and is included in eleven NDAs.

The generic ingredient in PROGESTERONE is progesterone. There are fifty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
Drug patent expirations by year for PROGESTERONE

Pharmacology for PROGESTERONE

Drug ClassProgesterone

Medical Subject Heading (MeSH) Categories for PROGESTERONE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms NyPROGESTERONEprogesteroneCAPSULE;ORAL207724-001Sep 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
LuitpoldPROGESTERONEprogesteroneINJECTABLE;INJECTION090845-001Jun 22, 2009AORXNoNo► Subscribe► Subscribe► Subscribe
Sandoz IncPROGESTERONEprogesteroneCAPSULE;ORAL205229-001Oct 20, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma IncPROGESTERONEprogesteroneCAPSULE;ORAL200900-002Aug 16, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva PharmsPROGESTERONEprogesteroneCAPSULE;ORAL202121-002Feb 29, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz IncPROGESTERONEprogesteroneCAPSULE;ORAL205229-002Oct 20, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
LillyPROGESTERONEprogesteroneINJECTABLE;INJECTION009238-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaPROGESTERONEprogesteroneINJECTABLE;INJECTION075906-001Apr 25, 2001AORXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms NyPROGESTERONEprogesteroneCAPSULE;ORAL207724-002Sep 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Bionpharma IncPROGESTERONEprogesteroneCAPSULE;ORAL200900-001Aug 16, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Express Scripts
Farmers Insurance
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: